Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | COVID-19 Vaccination | Research

Investigating the intention to receive the COVID-19 vaccination in Macao: implications for vaccination strategies

Authors: Carolina Oi Lam Ung, Yuanjia Hu, Hao Hu, Ying Bian

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

Understanding the intention of receiving COVID-19 vaccines is important to inform effective vaccination strategies. This study aimed to investigate such intention, identify the key influencing factors, and determine the most important intention predictors using a theoretically principled model.

Methods

An online, cross-sectional survey method was implemented in Macao in May 2021. People aged 18 years or above and residing in Macao for 12 months prior to the study were recruited through social media. Intention to receive COVID-19 vaccines and the main constructs of the protection motivation theory and the health belief model were the main measures encompassing threat appraisal, intrapersonal characteristics, cues to action, coping appraisal, past experiences and information seeking behavior. Descriptive statistics, Pearson correlation and multiple linear regression were used for data analysis.

Results

A total of 552 valid responses were received. Among the respondents, 79.5% aged between 25 and 54 years old, 59.4% were female, and 88% had a bachelor degree or above; 62.3% of the respondents indicated their intention to receive COVID-19 vaccination while 19.2% were hesitant and 18.5% did not have any intention. While 67.0% believed COVID-19 infection was life-threatening, only 19.0% thought they were at risk of getting infected. Control variables such as age, gender, education level, and having travel plans were significantly correlated with intention. Significant associations between intention with perceived severity, perceived susceptibility, maladaptive response reward, self-efficacy, response-efficacy, response cost, social attitude, social norm, past experience and information seeking behavior were identified (P < 0.05). The most important positive predictors of intention were “being able to make arrangement to receive the vaccine” (β = 0.333, P < 0.001), “a sense of social responsibility” (β = 0.326, P < 0.001), and “time off from work after vaccination” (β = 0.169, P < 0.001), whereas “concerns over vaccine safety” (β = − 0.124, P < 0.001) and “relying on online resources for vaccine information” (β = − 0.065, P < 0.05) were negative predictors. Perceived severity in terms of COVID-19 being a life threatening illness was not a predictor of intention.

Conclusion

This study reaffirmed that intention to receive COVID-19 vaccination is an ongoing concern in the combat of the pandemic. Multi-component strategies to enhance health literacy that supports well-informed decision-making, increase vaccination convenience, promote social responsibility, and provide time-off incentives are among the key considerations in designing and improve vaccination campaigns in Macao.
Literature
3.
go back to reference World Health Organization. Strengthening the health system response to COVID-19: technical guidance# 1: maintaining the delivery of essential health care services while mobilizing the health workforce for the COVID-19 response, 18 April 2020. World Health Organization. Regional Office for Europe; 2020. World Health Organization. Strengthening the health system response to COVID-19: technical guidance# 1: maintaining the delivery of essential health care services while mobilizing the health workforce for the COVID-19 response, 18 April 2020. World Health Organization. Regional Office for Europe; 2020.
6.
go back to reference Callaway E. The race for coronavirus vaccines: a graphical guide. Nature. 2020;580:576–7.PubMed Callaway E. The race for coronavirus vaccines: a graphical guide. Nature. 2020;580:576–7.PubMed
7.
go back to reference Le TT, Andreadakis Z, Kumar A, Román RG, Tollefsen S, Saville M, Mayhew S. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305–6. Le TT, Andreadakis Z, Kumar A, Román RG, Tollefsen S, Saville M, Mayhew S. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305–6.
8.
go back to reference Creech CB, Walker SC, Samuels RJ. SARS-CoV-2 vaccines. JAMA. 2021;325(13):1318–20.PubMed Creech CB, Walker SC, Samuels RJ. SARS-CoV-2 vaccines. JAMA. 2021;325(13):1318–20.PubMed
13.
go back to reference Haas EJ, Angulo FJ, McLaughlin JM, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021;397(10287):1819–29.PubMedPubMedCentral Haas EJ, Angulo FJ, McLaughlin JM, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021;397(10287):1819–29.PubMedPubMedCentral
22.
go back to reference MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4.PubMed MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4.PubMed
23.
go back to reference Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9(2):160.PubMedPubMedCentral Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9(2):160.PubMedPubMedCentral
24.
go back to reference Taylor S, Landry CA, Paluszek MM, et al. A proactive approach for managing COVID-19: the importance of understanding the motivational roots of vaccination hesitancy for SARS-CoV2. Front Psychol. 2020;11:2890. Taylor S, Landry CA, Paluszek MM, et al. A proactive approach for managing COVID-19: the importance of understanding the motivational roots of vaccination hesitancy for SARS-CoV2. Front Psychol. 2020;11:2890.
26.
go back to reference Sallam M, Dababseh D, Eid H, et al. High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: a study in Jordan and Kuwait among other Arab countries. Vaccines. 2021;9(1):42.PubMedPubMedCentral Sallam M, Dababseh D, Eid H, et al. High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: a study in Jordan and Kuwait among other Arab countries. Vaccines. 2021;9(1):42.PubMedPubMedCentral
27.
go back to reference Wong MC, Wong EL, Huang J, et al. Acceptance of the COVID-19 vaccine based on the health belief model: a population-based survey in Hong Kong. Vaccine. 2021;39(7):1148–56.PubMedPubMedCentral Wong MC, Wong EL, Huang J, et al. Acceptance of the COVID-19 vaccine based on the health belief model: a population-based survey in Hong Kong. Vaccine. 2021;39(7):1148–56.PubMedPubMedCentral
28.
go back to reference Li L, Wang J, Nicholas S, Maitland E, Leng A, Liu R. The intention to receive the COVID-19 vaccine in China: insights from protection motivation theory. Vaccines. 2021;9(5):445.PubMedPubMedCentral Li L, Wang J, Nicholas S, Maitland E, Leng A, Liu R. The intention to receive the COVID-19 vaccine in China: insights from protection motivation theory. Vaccines. 2021;9(5):445.PubMedPubMedCentral
29.
go back to reference Betsch C, Böhm R, Chapman GB. Using behavioral insights to increase vaccination policy effectiveness. Policy Insights Behav Brain Sci. 2015;2(1):61–73. Betsch C, Böhm R, Chapman GB. Using behavioral insights to increase vaccination policy effectiveness. Policy Insights Behav Brain Sci. 2015;2(1):61–73.
30.
go back to reference Camerini AL, Diviani N, Fadda M, et al. Using protection motivation theory to predict intention to adhere to official MMR vaccination recommendations in Switzerland. SSM Popul Health. 2019;7:100321. Camerini AL, Diviani N, Fadda M, et al. Using protection motivation theory to predict intention to adhere to official MMR vaccination recommendations in Switzerland. SSM Popul Health. 2019;7:100321.
31.
go back to reference Lazarus JV, Ratzan SC, Palayew A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–8.PubMed Lazarus JV, Ratzan SC, Palayew A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–8.PubMed
32.
go back to reference Billah MA, Miah MM, Khan MN. Reproductive number of coronavirus: a systematic review and meta-analysis based on global level evidence. PLoS ONE. 2020;15(11):e0242128.PubMedPubMedCentral Billah MA, Miah MM, Khan MN. Reproductive number of coronavirus: a systematic review and meta-analysis based on global level evidence. PLoS ONE. 2020;15(11):e0242128.PubMedPubMedCentral
33.
go back to reference Anderson RM, Vegvari C, Truscott J, Collyer BS. Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination. Lancet. 2020;396(10263):1614–6.PubMedPubMedCentral Anderson RM, Vegvari C, Truscott J, Collyer BS. Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination. Lancet. 2020;396(10263):1614–6.PubMedPubMedCentral
34.
go back to reference Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ. 2007;85:867–72. Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ. 2007;85:867–72.
38.
go back to reference World Health Organization. Behavioural considerations for acceptance and uptake of COVID-19 vaccines: WHO technical advisory group on behavioural insights and sciences for health, meeting report, 15 October 2020. 2020. Geneva: World Health Organization; 2020. World Health Organization. Behavioural considerations for acceptance and uptake of COVID-19 vaccines: WHO technical advisory group on behavioural insights and sciences for health, meeting report, 15 October 2020. 2020. Geneva: World Health Organization; 2020.
39.
go back to reference Head KJ, Kasting ML, Sturm LA, Hartsock JA, Zimet GD. <covid19> A national survey assessing SARS-CoV-2 vaccination intentions: implications for future public health communication efforts. Sci Commun. 2020;42(5):698–723.PubMedCentral Head KJ, Kasting ML, Sturm LA, Hartsock JA, Zimet GD. <covid19> A national survey assessing SARS-CoV-2 vaccination intentions: implications for future public health communication efforts. Sci Commun. 2020;42(5):698–723.PubMedCentral
40.
go back to reference Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated? Vaccine. 2020;38(42):6500–7.PubMedPubMedCentral Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated? Vaccine. 2020;38(42):6500–7.PubMedPubMedCentral
41.
go back to reference Wong LP, Alias H, Wong P-F, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccin Immunother. 2020;16(9):2204–14.PubMedPubMedCentral Wong LP, Alias H, Wong P-F, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccin Immunother. 2020;16(9):2204–14.PubMedPubMedCentral
42.
go back to reference Ansari-Moghaddam A, Seraji M, Sharafi Z, Mohammadi M, Okati-Aliabad H. The protection motivation theory for predict intention of COVID-19 vaccination in Iran: a structural equation modeling approach. BMC Public Health. 2021;21(1):1–9. Ansari-Moghaddam A, Seraji M, Sharafi Z, Mohammadi M, Okati-Aliabad H. The protection motivation theory for predict intention of COVID-19 vaccination in Iran: a structural equation modeling approach. BMC Public Health. 2021;21(1):1–9.
43.
go back to reference Dubé E, Vivion M, MacDonald NE. Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications. Expert Rev Vaccines. 2015;14(1):99–117.PubMed Dubé E, Vivion M, MacDonald NE. Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications. Expert Rev Vaccines. 2015;14(1):99–117.PubMed
44.
go back to reference Leavy P. Research design: quantitative, qualitative, mixed methods, arts-based, and community-based participatory research approaches. New York: Guildord Press; 2017. Leavy P. Research design: quantitative, qualitative, mixed methods, arts-based, and community-based participatory research approaches. New York: Guildord Press; 2017.
45.
go back to reference Wang K, Wong EL-Y, Ho K-F, et al. Change of willingness to accept COVID-19 vaccine and reasons of vaccine hesitancy of working people at different waves of local epidemic in Hong Kong, China: repeated cross-sectional surveys. Vaccines. 2021;9(1):62. Wang K, Wong EL-Y, Ho K-F, et al. Change of willingness to accept COVID-19 vaccine and reasons of vaccine hesitancy of working people at different waves of local epidemic in Hong Kong, China: repeated cross-sectional surveys. Vaccines. 2021;9(1):62.
46.
48.
go back to reference Wang J, Lu X, Lai X, et al. The changing acceptance of COVID-19 vaccination in different epidemic phases in China: a longitudinal study. Vaccines. 2021;9(3):191.PubMedPubMedCentral Wang J, Lu X, Lai X, et al. The changing acceptance of COVID-19 vaccination in different epidemic phases in China: a longitudinal study. Vaccines. 2021;9(3):191.PubMedPubMedCentral
49.
go back to reference Rhodes A, Hoq M, Measey M-A, Danchin M. Intention to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2021;21(5):e110.PubMed Rhodes A, Hoq M, Measey M-A, Danchin M. Intention to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2021;21(5):e110.PubMed
50.
go back to reference Neumann-Böhme S, Varghese NE, Sabat I, et al. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020;21:977–82.PubMedPubMedCentral Neumann-Böhme S, Varghese NE, Sabat I, et al. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020;21:977–82.PubMedPubMedCentral
51.
go back to reference Dubé E, MacDonald NE. Vaccine acceptance: barriers, perceived risks, benefits, and irrational beliefs. In: The vaccine book. Amsterdam: Elsevier; 2016. pp. 507–28. Dubé E, MacDonald NE. Vaccine acceptance: barriers, perceived risks, benefits, and irrational beliefs. In: The vaccine book. Amsterdam: Elsevier; 2016. pp. 507–28.
52.
go back to reference Detoc M, Bruel S, Frappe P, et al. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020;38(45):7002–6.PubMedPubMedCentral Detoc M, Bruel S, Frappe P, et al. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020;38(45):7002–6.PubMedPubMedCentral
53.
go back to reference Khubchandani J, Sharma S, Price JH, Wiblishauser MJ, Sharma M, Webb FJ. COVID-19 vaccination hesitancy in the United States: a rapid national assessment. J Community Health. 2021;46(2):270–7.PubMed Khubchandani J, Sharma S, Price JH, Wiblishauser MJ, Sharma M, Webb FJ. COVID-19 vaccination hesitancy in the United States: a rapid national assessment. J Community Health. 2021;46(2):270–7.PubMed
54.
go back to reference Dodd RH, Cvejic E, Bonner C, et al. Willingness to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2021;21(3):318–9.PubMed Dodd RH, Cvejic E, Bonner C, et al. Willingness to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2021;21(3):318–9.PubMed
55.
go back to reference Adler NE, Newman K. Socioeconomic disparities in health: pathways and policies. Health Aff. 2002;21(2):60–76. Adler NE, Newman K. Socioeconomic disparities in health: pathways and policies. Health Aff. 2002;21(2):60–76.
56.
go back to reference Kunst AE, Bos V, Lahelma E, et al. Trends in socioeconomic inequalities in self-assessed health in 10 European countries. Int J Epidemiol. 2005;34(2):295–305.PubMed Kunst AE, Bos V, Lahelma E, et al. Trends in socioeconomic inequalities in self-assessed health in 10 European countries. Int J Epidemiol. 2005;34(2):295–305.PubMed
58.
go back to reference Biasio LR. Vaccine hesitancy and health literacy. Hum Vaccin Immunother. 2017;13(3):701–2.PubMed Biasio LR. Vaccine hesitancy and health literacy. Hum Vaccin Immunother. 2017;13(3):701–2.PubMed
59.
go back to reference Nutbeam D. The evolving concept of health literacy. Soc Sci Med. 2008;67(12):2072–8.PubMed Nutbeam D. The evolving concept of health literacy. Soc Sci Med. 2008;67(12):2072–8.PubMed
60.
go back to reference Lorini C, Santomauro F, Donzellini M, et al. Health literacy and vaccination: a systematic review. Hum Vaccin Immunother. 2018;14(2):478–88.PubMed Lorini C, Santomauro F, Donzellini M, et al. Health literacy and vaccination: a systematic review. Hum Vaccin Immunother. 2018;14(2):478–88.PubMed
62.
go back to reference Zampetakis LA, Melas C. The health belief model predicts vaccination intentions against COVID-19: a survey experiment approach. Appl Psychol Health Well Being. 2021;13(2):469–84.PubMed Zampetakis LA, Melas C. The health belief model predicts vaccination intentions against COVID-19: a survey experiment approach. Appl Psychol Health Well Being. 2021;13(2):469–84.PubMed
63.
go back to reference Sherman SM, Smith LE, Sim J, et al. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 2021;17(6):1612–21.PubMed Sherman SM, Smith LE, Sim J, et al. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 2021;17(6):1612–21.PubMed
64.
go back to reference Shmueli L. Predicting intention to receive COVID-19 vaccine among the general population using the health belief model and the theory of planned behavior model. BMC Public Health. 2021;21(1):1–3. Shmueli L. Predicting intention to receive COVID-19 vaccine among the general population using the health belief model and the theory of planned behavior model. BMC Public Health. 2021;21(1):1–3.
66.
go back to reference Latkin CA, Dayton L, Yi G, et al. Trust in a COVID-19 vaccine in the US: a social-ecological perspective. Soc Sci Med. 2021;270:113684.PubMedPubMedCentral Latkin CA, Dayton L, Yi G, et al. Trust in a COVID-19 vaccine in the US: a social-ecological perspective. Soc Sci Med. 2021;270:113684.PubMedPubMedCentral
68.
go back to reference Chevallier C, Hacquin A-S, Mercier H. COVID-19 vaccine hesitancy: shortening the last mile. Trends Cogn Sci. 2021;25(5):331–3.PubMedPubMedCentral Chevallier C, Hacquin A-S, Mercier H. COVID-19 vaccine hesitancy: shortening the last mile. Trends Cogn Sci. 2021;25(5):331–3.PubMedPubMedCentral
69.
go back to reference Brewer NT, Chapman GB, Rothman AJ, Leask J, Kempe A. Increasing vaccination: putting psychological science into action. Psychol Sci Public Interest. 2017;18(3):149–207.PubMed Brewer NT, Chapman GB, Rothman AJ, Leask J, Kempe A. Increasing vaccination: putting psychological science into action. Psychol Sci Public Interest. 2017;18(3):149–207.PubMed
70.
go back to reference Maddux JE, Rogers RW. Protection motivation and self-efficacy: a revised theory of fear appeals and attitude change. J Exp Soc Psychol. 1983;19(5):469–79. Maddux JE, Rogers RW. Protection motivation and self-efficacy: a revised theory of fear appeals and attitude change. J Exp Soc Psychol. 1983;19(5):469–79.
71.
go back to reference Britt RK, Hatten KN, Chappuis SO. Perceived behavioral control, intention to get vaccinated, and usage of online information about the human papillomavirus vaccine. Health Psychol Behav Med. 2014;2(1):52–65.PubMed Britt RK, Hatten KN, Chappuis SO. Perceived behavioral control, intention to get vaccinated, and usage of online information about the human papillomavirus vaccine. Health Psychol Behav Med. 2014;2(1):52–65.PubMed
72.
go back to reference Goralnick E, Kaufmann C, Gawande AA. Mass-vaccination sites—an essential innovation to curb the covid-19 pandemic. N Engl J Med. 2021;384(18):e67.PubMed Goralnick E, Kaufmann C, Gawande AA. Mass-vaccination sites—an essential innovation to curb the covid-19 pandemic. N Engl J Med. 2021;384(18):e67.PubMed
74.
go back to reference Brown KF, Kroll JS, Hudson MJ, et al. Factors underlying parental decisions about combination childhood vaccinations including MMR: a systematic review. Vaccine. 2010;28(26):4235–48.PubMed Brown KF, Kroll JS, Hudson MJ, et al. Factors underlying parental decisions about combination childhood vaccinations including MMR: a systematic review. Vaccine. 2010;28(26):4235–48.PubMed
76.
go back to reference Stiglitz JE, Rosengard JK. Economics of the public sector. 4th ed. New York: W.W. Norton & Company; 2015. Stiglitz JE, Rosengard JK. Economics of the public sector. 4th ed. New York: W.W. Norton & Company; 2015.
78.
go back to reference Phelan AL. COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges. Lancet. 2020;395(10237):1595–8.PubMedPubMedCentral Phelan AL. COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges. Lancet. 2020;395(10237):1595–8.PubMedPubMedCentral
80.
go back to reference Giles EL, Robalino S, McColl E, Sniehotta FF, Adams J. The effectiveness of financial incentives for health behaviour change: systematic review and meta-analysis. PLoS ONE. 2014;9(3):e90347.PubMedPubMedCentral Giles EL, Robalino S, McColl E, Sniehotta FF, Adams J. The effectiveness of financial incentives for health behaviour change: systematic review and meta-analysis. PLoS ONE. 2014;9(3):e90347.PubMedPubMedCentral
82.
go back to reference Adams J, Giles EL, McColl E, Sniehotta FF. Carrots, sticks and health behaviours: a framework for documenting the complexity of financial incentive interventions to change health behaviours. Health Psychol Rev. 2014;8(3):286–95.PubMed Adams J, Giles EL, McColl E, Sniehotta FF. Carrots, sticks and health behaviours: a framework for documenting the complexity of financial incentive interventions to change health behaviours. Health Psychol Rev. 2014;8(3):286–95.PubMed
83.
go back to reference Betsch C, Sachse K. Dr. Jekyll or Mr. Hyde? (How) the Internet influences vaccination decisions: recent evidence and tentative guidelines for online vaccine communication. Vaccine 2012;25(30):3723–6. Betsch C, Sachse K. Dr. Jekyll or Mr. Hyde? (How) the Internet influences vaccination decisions: recent evidence and tentative guidelines for online vaccine communication. Vaccine 2012;25(30):3723–6.
84.
go back to reference Godlee F. What should we do about vaccine hesitancy? BMJ. 2019;365:l40–4. Godlee F. What should we do about vaccine hesitancy? BMJ. 2019;365:l40–4.
85.
go back to reference Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021;S2468–2667(21):00012–8. Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021;S2468–2667(21):00012–8.
86.
go back to reference Karafillakis E, Dinca I, Apfel F, et al. Vaccine hesitancy among healthcare workers in Europe: a qualitative study. Vaccine. 2016;34(41):5013–20.PubMed Karafillakis E, Dinca I, Apfel F, et al. Vaccine hesitancy among healthcare workers in Europe: a qualitative study. Vaccine. 2016;34(41):5013–20.PubMed
Metadata
Title
Investigating the intention to receive the COVID-19 vaccination in Macao: implications for vaccination strategies
Authors
Carolina Oi Lam Ung
Yuanjia Hu
Hao Hu
Ying Bian
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07191-y

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine